Other News To Note
Medigene AG, of Martinsried, Germany, said genital warts treatment Veregen obtained market approval in Serbia. The drug will be launched there in the second half of this year.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.